Yenisel Cruz-Almeida, Ph.D., has been appointed the director of Clinical and Translational Research for the University of Florida College of Dentistry, or UFCD.
Cruz-Almeida, a professor in the UF Department of Community Dentistry & Behavioral Science, and associate director of the UF Pain Research and Intervention Center of Excellence, also has appointments in the UF College of Medicine’s Department of Neuroscience and the UF College of Public Health & Health Professions’ Department of Epidemiology.
In her new role as director of Clinical and Translational Research, or CTR, she is providing direction and supporting initiatives elevating UFCD’s translational research agenda, building interdisciplinary teams and strategic partnerships to accelerate bench-to-bedside innovation that advances patient outcomes and shapes the future of personalized healthcare.
“Dr. Cruz-Almeida has multidisciplinary expertise spanning preclinical and clinical research, epidemiology and neuroscience. This knowledge base gives her a unique ability to build a transformative research framework that bridges the continuum from discovery to clinical application, that advances patient outcomes and inform precision care,” said A. Isabel Garcia, UFCD dean.
Cruz-Almeida will coordinate her efforts with UFCD leadership in research and in planning and institutional effectiveness, to ensure that the college’s translational research supports all areas of the college missions, and strategic plans and initiatives.
Cruz-Almeida earned her bachelor’s in microbiology and cell science from UF in 2001, her master’s in epidemiology and public health with a concentration in biostatistics in 2004, and her doctorate in neuroscience in 2011, both from the University of Miami.
Cruz-Almeida is a clinical translational neuroscientist specializing in pain mechanisms across the lifespan. Using psychophysics, neuroimaging and epigenetics, she identifies nervous system factors underlying individual pain variability and functional outcomes. Her approach bridges basic neuroscience, clinical outcomes, and population health—uniquely positioning her to lead UFCD’s translational research enterprise.
Source: https://dental.ufl.edu/
HSDM director of admissions reflects on the rewarding aspects of her work as she is recognized for her contributions to HSDM
News 24 March 2026
The board of directors of Colgate-Palmolive Company (NYSE:CL) recently announced an increase in the quarterly common stock cash dividend to $0.53 up from $0.52 per share.
Dr. Todd Gray, passion, for oral healthcare aligns with Sun Life and TeamSmile missions to provide children in need with life-changing dental care
Products 20 February 2026
Georgia School of Orthodontics (GSO) announced the appointment of Mohamed I. Masoud, BDS, DMSc, a Diplomate of the American Board of Orthodontics, as its new Director of Research. A distinguished...
Products 13 February 2026
Parkview Dental, a leading Dental Support Organization committed to providing comprehensive management services to dental practices, announced the appointment of Lisa Burris as its new Director of...
New initiative invites dentists to experience DEXIS’ most advanced AI yet, built on scale, speed, and clinical trust.
News 05 June 2026
(Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/C
News 05 June 2026
(Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected Will
As the University of Colorado School of Dental Medicine celebrates the graduating DDS Class of 2025, we are proud to recognize the students and faculty members whose exceptional de
Oral surgery 05 June 2026
This peer-reviewed oral surgery article summarizes clinical evidence from International journal of oral and maxillofacial surgery (2026). It focuses on findings that may help dental professionals...